We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fluorescence Analyzers Evaluated for Diagnoses of UTIs

By LabMedica International staff writers
Posted on 10 Sep 2018
Print article
Image: The UF-5000 Urine fluorescence flow cytometry analyzer (Photo courtesy of Sysmex).
Image: The UF-5000 Urine fluorescence flow cytometry analyzer (Photo courtesy of Sysmex).
Urinary tract infections (UTIs) are among the most frequent infections in both hospitalized and outpatients. As a result, urine specimens constitute a significant proportion of routine microbiology laboratory workload.

Traditional culture remains the “gold standard” for the diagnostic evaluation of patients suspected of having a UTI as it allows the identification of the etiological agents, to estimate the concentration of isolated microorganisms and to offer susceptibility testing for targeting the optimal antibiotic therapy.

Medical microbiologists at the Pordenone Hub Hospital (Pordenone, Italy) evaluated 2,719 midstream urine samples from 1,198 (44.1%) male and 1,521 (55.9%) female, aged from 0 and 97 years (median age = 66 years), submitted to the microbiology laboratory with a specific request for urine culture. Inpatients were 23.9% and outpatients 76.1%. The study was conducted from April 6 to June 12, 2017.

All specimens that passed an exclusion criterion were analyzed with the Sysmex UF-5000 (Sysmex Corporation, Kobe, Japan). The analyzer can discriminate and count 17 diagnostic parameters of cells and formed elements in urine and offers an integrated body fluid mode (BF), available on the instrument with a switch, which can classify and count seven diagnostic parameters. The system employs fluorescence flow cytometry technology, using a new blue semi-conductor laser at 488 nm wavelength, Gram staining of centrifuged specimens was conducted in case of discrepancies between the results of the UF-5000 Bact Info flag and the culture method.

The scientists reported that of the 2,719 samples, 1,922 (70.7%) were negative in urine culture (sterile or ≤ 104 CFU/mL) and 797 (29.3%) showed significant growth. In 574 of the positive samples a single microorganism was identified, in 71 samples two microorganisms were isolated, and 152 samples showed mixed flora. The microorganisms isolated reflected the usual rate of uropathogens in their laboratory, so that the most frequent bacteria reported were Gram negatives accounting for 76.9% of all species isolated, and the majority were Enterobacteriaceae. The UF-5000 showed a very good performance in the screening process. Carryover and cross-contamination was negligible and 797 samples were culture positive at a cut-off of ≥105CFU/mL.

The authors concluded that the new Sysmex UF-5000 showed high diagnostic accuracy in UTI-screening with a very low rate of false negatives. The instrument is capable of predicting Gram negatives with a good standard error and a high agreement with the culture, even if this performance needs further evaluation. The study was published in the September 2018 issue of the journal Clinica Chimica Acta.

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Refrigerated Microtube Homogenizer
BeadBlaster 24R
New
Rheumatoid Arthritis Test
Finecare RF Rapid Quantitative Test

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.